Prellisbio
1 known investors
Prellis develops an AI-enabled platform for antibody discovery using 3D-printed organoids that recapture human immune biology, generating therapeutic antibody candidates for multiple disease areas. The platform combines machine learning with wet lab characterization to accelerate the development of fully human antibody therapeutics.
AI & Machine LearningBiotechDeep Tech